Brain/Spinal Cord Cancers

 

Radiation Therapy With or Without Temozolomide for Anaplastic Glioma (7880)
Phase III Trial On Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1P/19Q Deleted Anaplastic Glioma: The CATNON Intergroup Trial (RTOG 0834)

Investigator: George Laramore, MD, PhD;   Conditions: Brain and Central Nervous System Tumors;    Status: Recruiting;   Study ID: NCT00626990

Chemotherapy Plus Chemoprotected Autologous Stem Cells for Malignant Gliomas (FHCRC-2000)
Dose-Intensive Chemotherapy in Combination with Chemoprotected Autologous Stem Cells for Patients with Malignant Gliomas

Investigator: Hans-Peter Kiem, MD;   Conditions: Brain Cancer; Glioma; Solid Tumors;    Status: Recruiting;   Study ID: NCT00669669

Radiation w/wo Temozolomide for Low-Grade Gliomas (7269)
Phase III Study of Radiation Therapy With or Without Temozolomide For Symptomatic or Progressive Low-Grade Gliomas

Investigator: George Laramore, MD;   Conditions: Brain and Central Nervous System Tumors, Neurotoxicity Syndromes;    Status: Recruiting;   Study ID: NCT00978458

Radiation Therapy w/wo Cediranib Maleate for Newly Diagnosed Glioblastoma (7196)
Randomized, Phase II, Double-Blind, Placebo-Controlled Trial of Conventional Chemoradiation and Adjuvant Temozolomide Plus Cediranib Versus Conventional Chemoradiation and Adjuvant Temozolomide Plus Placebo in Patients with Newly Diagnosed Glioblastoma

Investigator: George Laramore, MD;   Conditions: Brain and Central Nervous System Tumors;    Status: Closed;   Study ID: NCT01062425

PPX and Concurrent Radiation for Newly Diagnosed Glioblastoma Without MGMT Methylation (7591)
PPX and Concurrent Radiation for Newly Diagnosed Glioblastoma Without MGMT Methylation: A Randomized Phase II Study: BrUOG 244

Investigator: Maciej Mrugala, MD, PhD;   Conditions: Astrocytomas; Brain Cancer; Central Nervous System (CNS); Glioblastoma Multiforme; Solid Tumors;    Status: Recruiting;   Study ID: NCT01402063